Gabriel Ozorowski

56PUBLICATIONS
441CO-AUTHORS
Medical infection agents (incl. prions)Innate immunityManufacturing safety and qualityMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Jul 14, 2026
Structural basis of membrane engagement and polyreactivity control in HIV-1 MPER broadly neutralizing antibodies.

|Jul 01, 2026
Vaccination elicits HIV broadly neutralizing antibodies in primates.

|Jun 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144.

|Apr 29, 2026
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex.

|Feb 10, 2026
Virus glycoprotein nanodisc platform for vaccine analytics.

Kimmo Rantalainen, Alessia Liguori, Gabriel Ozorowski

|Feb 02, 2026
Signatures of native-like glycosylation in RNA replicon-derived HIV-1 immunogens.

Himanshi Chawla, Jacob T Willcox, Grace M Hayes

Pageof 10

Frequent Collaborators

49 joint publications

Andrew B Ward

18 joint publications

Christopher A Cottrell

17 joint publications

Dennis R Burton

17 joint publications

William R Schief